Market Overview

UPDATE: Jefferies Downgrades HealthSouth Corporation to Hold on Regulatory Headwinds

Share:
Related HLS
Benzinga's Top Upgrades, Downgrades For February 14, 2017
Companies That Have The Most To Lose If Obamacare Is Repealed

Jefferies lowered its HealthSouth Corporation (NYSE: HLS) rating from Buy to Hold and reduced its price target from $25 to $23.

Jefferies noted, "HLS's strong Q2 performance and raised guidance was impressive, but we recommend taking advantage of stock strength to lighten long positions, fearing that IRF reimbursement could get greater scrutiny later this year when legislators look for funding offsets to another doc fix and deficit reduction."

HealthSouth Corporation closed at $22.93 on Thursday.

Latest Ratings for HLS

DateFirmActionFromTo
Feb 2017Craig-HallumInitiates Coverage OnBuy
Feb 2017Craig-HallumInitiates Coverage OnBuy
Jan 2017PiperJaffrayInitiates Coverage OnNeutral

View More Analyst Ratings for HLS
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (HLS)

View Comments and Join the Discussion!